Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Ulcerative Colitis (UC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01008410
What this trial is testing

Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

Who this might be right for
ProctitisProctosigmoiditis
Bausch Health Americas, Inc. 265
Not applicableActive Not RecruitingNCT05496348
What this trial is testing

Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 400
Post-approval studies (Phase 4)Ended earlyNCT00947674
What this trial is testing

Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Asahi Kasei Medical Co., Ltd. 52
Testing effectiveness (Phase 2)Study completedNCT04102852
What this trial is testing

Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients

Who this might be right for
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate
San Giovanni Addolorata Hospital 76
Testing effectiveness (Phase 2)Looking for participantsNCT06764615
What this trial is testing

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda 192
Large-scale testing (Phase 3)Ended earlyNCT01349673
What this trial is testing

The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis

Who this might be right for
ProctitisProctosigmoiditis
Bausch Health Americas, Inc. 114
Large-scale testing (Phase 3)Study completedNCT01745770
What this trial is testing

TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)

Who this might be right for
Active Ulcerative Colitis
Dr. Falk Pharma GmbH 306
Post-approval studies (Phase 4)Not Yet RecruitingNCT07782242
What this trial is testing

Comaprison of Efficacy and Safety Between Etrasimod vs Mesalazine in Chinese Adults With Active UC

Who this might be right for
EtrasimodMesalazineUlcerative Colitis (UC)+1 more
Sir Run Run Shaw Hospital 320
Not applicableLooking for participantsNCT06073873
What this trial is testing

A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 3,000
Testing effectiveness (Phase 2)Ended earlyNCT04677179
What this trial is testing

LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Nektar Therapeutics 81
Large-scale testing (Phase 3)Study completedNCT02522767
What this trial is testing

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Ferring Pharmaceuticals 228
Large-scale testing (Phase 3)Study completedNCT04630028
What this trial is testing

Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 112
Large-scale testing (Phase 3)Study completedNCT03653026
What this trial is testing

The Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 522
Not applicableStudy completedNCT04753775
What this trial is testing

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.

Who this might be right for
Aloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC)
Ospedale Sandro Pertini, Roma 44
Large-scale testing (Phase 3)Ended earlyNCT01805791
What this trial is testing

A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Hutchison Medipharma Limited 201
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Testing effectiveness (Phase 2)Looking for participantsNCT07513181
What this trial is testing

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesAutoimmune Diseases
Athos Therapeutics Inc 120
Post-approval studies (Phase 4)Study completedNCT02318667
What this trial is testing

Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).

Who this might be right for
Colitis, Ulcerative
Merck Sharp & Dohme LLC 38
Testing effectiveness (Phase 2)Looking for participantsNCT07374471
What this trial is testing

MB-001 in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Mage Biologics 100
Not applicableLooking for participantsNCT06764706
What this trial is testing

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 200
Next Page